| A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors Using Third-generation EGFR-TKIs. (NCT07686185) | First Affiliated Hospital of Guangxi Medical University | 2026-09-01 |
| Impacted Tooth Management and Osteoradionecrosis Risk in NPC (NCT07764887) | First Affiliated Hospital of Guangxi Medical University | 2026-08-30 |
| An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models (NCT07555756) | First Affiliated Hospital of Guangxi Medical University | 2026-05-01 |
| Multi-Site Cortical Puncture for DOR (NCT07568639) | First Affiliated Hospital of Guangxi Medical University | 2026-04-30 |
| Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging (NCT07475949) | First Affiliated Hospital of Guangxi Medical University | 2026-04-01 |
| Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke (NCT07475936) | First Affiliated Hospital of Guangxi Medical University | 2026-04-01 |
| Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC (NCT07459296) | First Affiliated Hospital of Guangxi Medical University | 2026-03-05 |
| A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma (NCT07342322) | First Affiliated Hospital of Guangxi Medical University | 2026-02-01 |
| Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML (NCT07338357) | First Affiliated Hospital of Guangxi Medical University | 2026-01-05 |
| Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Mucositis (NCT07312656) | First Affiliated Hospital of Guangxi Medical University | 2026-01-01 |
| Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer (NCT07132008) | First Affiliated Hospital of Guangxi Medical University | 2025-10-01 |
| Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel (NCT07074444) | First Affiliated Hospital of Guangxi Medical University | 2025-07-22 |
| Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects (NCT07040579) | First Affiliated Hospital of Guangxi Medical University | 2025-06-30 |
| Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected (NCT07623252) | First Affiliated Hospital of Guangxi Medical University | 2025-01-06 |
| A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia (NCT06678165) | First Affiliated Hospital of Guangxi Medical University | 2024-12-31 |
| Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma (NCT06680115) | First Affiliated Hospital of Guangxi Medical University | 2024-11-01 |
| The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer (NCT06254521) | First Affiliated Hospital of Guangxi Medical University | 2024-02-22 |
| Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer (NCT06124378) | First Affiliated Hospital of Guangxi Medical University | 2023-11-13 |
| Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy (NCT05892354) | First Affiliated Hospital of Guangxi Medical University | 2023-06-12 |
| A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants (NCT05757245) | First Affiliated Hospital of Guangxi Medical University | 2023-05-08 |
| CRUSTAL Study in China (NCT05828186) | First Affiliated Hospital of Guangxi Medical University | 2023-05-04 |
| Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM (NCT05677334) | First Affiliated Hospital of Guangxi Medical University | 2023-03-01 |
| A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT] (NCT05762510) | First Affiliated Hospital of Guangxi Medical University | 2023-02-22 |
| Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus (NCT06040177) | First Affiliated Hospital of Guangxi Medical University | 2023-02-02 |
| Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer (NCT05511623) | First Affiliated Hospital of Guangxi Medical University | 2022-09-01 |
| Edaravone in the Treatment of Optic Neuritis (NCT05540262) | First Affiliated Hospital of Guangxi Medical University | 2022-01-15 |
| PCP in Immunocompromised Population in Southern China (NCT05605145) | First Affiliated Hospital of Guangxi Medical University | 2021-05-12 |
| Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma (NCT04447326) | First Affiliated Hospital of Guangxi Medical University | 2020-06-01 |
| Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder (NCT05896605) | First Affiliated Hospital of Guangxi Medical University | 2020-01-01 |
| Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study (NCT04009525) | First Affiliated Hospital of Guangxi Medical University | 2019-07-05 |
| Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer (NCT03649945) | First Affiliated Hospital of Guangxi Medical University | 2018-11-01 |
| Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC (NCT03654027) | First Affiliated Hospital of Guangxi Medical University | 2018-10-01 |
| A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma (NCT03609489) | First Affiliated Hospital of Guangxi Medical University | 2018-09-10 |
| Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma (NCT03114085) | First Affiliated Hospital of Guangxi Medical University | 2017-05-20 |
| Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major (NCT03171831) | First Affiliated Hospital of Guangxi Medical University | 2017-04-01 |
| Adjunctive Gypenosides for Acute Optic Neuritis (NCT02976766) | First Affiliated Hospital of Guangxi Medical University | 2017-02-04 |
| Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT02907710) | First Affiliated Hospital of Guangxi Medical University | 2016-10-01 |
| Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism (NCT03101423) | First Affiliated Hospital of Guangxi Medical University | 2016-08-01 |
| Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma (NCT02237924) | First Affiliated Hospital of Guangxi Medical University | 2014-09-01 |